FOLH1 and posterior cortical atrophy: Meanwhile, in terms of PSMA-617, which can be labeled with both 68Ga and 177Lu, its tumor-to-background ratio and clearance rate still need to be improved, due to its relatively low hydrophilicity and inherent pharmacokinetic characteristics, which are crucial to PCa therapy.